Home » Newsletters » BioWorld

BioWorld

July 8, 1993

View Archived Issues

IMMUNE RESPONSE REGISTERS SHARES

XYTRONYX RAISES $1.74 MILLION

TRIPLEX COLLABORATES WITH WISTAR RESEARCHER

VESTAR STARTS TRIALS

INTERLEUKIN SAVES MICE

OXFORD COMPLETES FUND-RAISING

GENICA READIES CMT DIAGNOSTIC

TRIALS OF DENTAL COMPOUND APPROVED

OPPOSITION FORMS AGAINST MEDICAID FORMULARIES

EPA REGISTERS ECOGEN BIOPESTICIDE

COLLABORATIVE SELLS TESTING BUSINESS

AGOURON HALTS TRIALS ON DRUG FOR PSORIASIS

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 16, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...